9%18%

(Asymptomatic microscopic
hematuria)2012

(<25RBC/HPF)

()

1989Mariani AJ

(>50RBC/
HPF)

0.01%3%

(5%13%)

(0.43%)

145

 JOURNAL OF KAOHSIUNG MEDICAL ASSOCIATION 2013. vol.21, No.2

(Hematuria Risk Index)

011(0-4
5-89-11
)()
()

Ta

T2

T3(T2)

<5%

>10%ROC
(receiver operating characteristic curve)
AUC(area under the curve)

2013.01.09
Mayo Clinic Proc.
Ronald K. Loo
2009.01.092011.08.15
Kaiser Permanente managed care

(X2 test)

()

(>50RBC/HPF)

(>25RBC/HPF)

146

T3 Total

(3) (111)

0
3

0
38

3
70

2001
2012

(Multi-phasic computed tomography

urography)

(intravenous urography)

(Solid mass)(Cystic mass)

(Ultrasonography)

Tis
(4)

Ta
(58)

T1
(36)

T2
(10)

(0-4)

(5-8)

19

15

(9-11)

36

21

( )

0.809/0.833

(Hematuria Risk Index)

2001

2012

(
)

147

 JOURNAL OF KAOHSIUNG MEDICAL ASSOCIATION 2013. vol.21, No.2

(retrograde
pyelography)

2%
2009

(Hematuria Risk
Index)

(Benefit)
(Outcome)

1.Rodney Davis, J. Stephen Jones, Daniel

A. Barocas, et al. DIAGNOSIS,
EVALUATION and FOLLOW-UP OF
ASYMPTOMATIC MICROHEMATURIA
(AMH) IN ADULTS: AUA GUIDELINE
2012
2. Ronald K. Loo, MD; Stephen F. Lieberman,
MD; Jeff M. Slezak, MS, et al. Stratifying
Risk of Urinary Tract Malignant Tumors in
Patients With Asymptomatic Microscopic
Hematuria Mayo Clinic Proc. 2013
3. Mohr DN, Offord KP, Owen RA, et al.
Asymptomatic microhematuria and urologic
disease: a population-based study. JAMA.
1986;256(2):224-229.
4 . F r e n i S C , F r e n i - T i t u l a e r L W.
Microhematuria found by mass screening
of apparently healthy males. Acta Cytol.
1977;21(3): 421-423.
5. Mariani AJ, Mariani MC, Macchioni C,
et al. The significance of adult hematuria:
1,000 hematuria evaluations including a
risk benet and cost-effectiveness analysis.
J Urol. 1989;141(2): 350-355.

148